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Abstract
Background: Within the sphere of diabetes self-management, much emphasis has been placed on medication
adherence. There has been a shift in thinking about medication adherence, moving from “compliance” and
historically paternalistic models of care, to seeking better ways of characterizing dynamic and complex relationships
that determine medication adherence and diabetes control. This study sought to understand the relationship
between patient’s attitudes and medication adherence for oral anti-diabetics in Thailand.
Methods: In-depth interviews of patients with type 2 diabetes mellitus, taking oral anti-diabetic drugs, at the out-
patient clinic run by the Department of Family Medicine, Chiang Mai University between May and December 2016.
Thematic analysis followed the WHO framework for medication adherence in chronic disease to explore patient’s
attitudes and their influence on medication compliance.
Results: Of 24 patients, 9 were men. The mean age was 62 years (SD 8.9 years). 67% had high compliance. Four
themes were identified as important factors related to medication adherence: attitudes toward disease, attitudes
toward treatment, attitudes toward family support and attitudes toward health care team. Specifically, symptoms at
diagnosis, understanding and acceptance in taking medication, the presence of family support and the perception
of concern by the doctor relate to improved medication compliance.
Conclusions: Medication adherence in Thai patients with diabetes requires support from both the health care
providers and the family. The patient’s perception of the doctor’s concern creates greater patient trust in the health
care team. This trust, along with family support, helps deepen patients’ understanding of the disease, accept the
chronic nature of their disease, and engenders a positive attitude towards taking medication that can improve
medication adherence.
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Background
Type 2 diabetes mellitus (T2DM) affects populations
worldwide. In 2017, there were an estimated 425 million
(CI 346–545 million) people between 20 and 79 years
globally with diabetes and it is predicted to rise to nearly
630 million affected and a prevalence nearing 10% by
2045 [1].
This has become a formidable health challenge facing
low- and middle-income countries (LMIC) such as
Thailand. Trebling over the previous two decades, there
were an estimated 4 million Thai adults living with dia-
betes by 2015 [2, 3]. Diabetes is the cause of death in 11,
389 per 100,000 deaths, has one of the highest preva-
lence in the Western Pacific Region nearing 8% among
20–79 year-olds, and is the 5th leading cause of disability
in Thailand [3, 4]. Studies have demonstrated the con-
siderable social and economic costs associated with
T2DM in Thailand [5, 6].
Given Thailand’s strong primary health system and
universal health coverage, medical management of
T2DM is widely available [2]. However, surveys of pa-
tients with diabetes in Thailand document that less than
half achieve optimal control of clinical risk factors for
disease: with 33% of patients achieving optimal HbA1C
levels; 44% maintaining appropriate LDL cholesterol
levels; and 52% with appropriate blood pressure control.
Regular follow-up and screening for microvascular com-
plications is similarly limited, with fewer than 60% of pa-
tients with diabetes in Thailand receiving comprehensive
annual screening [2, 7]. However, T2DM management
and preventing its complications requires not only ac-
cess to and utilization of facility-based services, but also
appropriate self-management of disease. T2DM patients
therefore need to incorporate a number of lifestyle
changes that allow for medication adherence, appropri-
ate diet, and adequate exercise. Given the chronic nature
of this disease, patients must develop the knowledge,
skills and abilities for adequate self-management [8].
Within this sphere of T2DM self-management, much
emphasis has been placed on medication adherence.
There has been a shift in thinking about medication ad-
herence, diverging from notions of “compliance” and his-
torically paternalistic models of care, to seeking better
ways of characterizing dynamic and complex relationships
that determine medication adherence and diabetes con-
trol. The WHO, in highlighting the need for a stronger
health systems approach to medication adherence for
chronic disease, asserted that medication adherence in
diabetes hinged upon five key factors: therapy-related
factors, condition-related factors, health systems/health
care team (HCT)-related factors, patient-related factors,
and social/economic-related factors [9]. Therapy-, condi-
tion-, and health systems/HCT-related factors consider
the complexity of the medication regimen, the duration of
the disease, delivery of care, and patient-provider relation-
ships. In addition to age and gender, other patient-related
factors such as self-esteem, self-efficacy, depression and al-
cohol abuse can impact medication adherence. Social/eco-
nomic-related factors often consider cost of medicines
and care, as well as social support networks.
Thailand, as in other LMIC, has few robust studies
characterizing lifestyle factors as they impact anti-
diabetic medication adherence and T2DM management.
Studies conducted in Thailand have attempted to make
the link between T2DM indicators and patient adher-
ence to medication, but these studies do not provide a
convincing, plausible relationship due to limitations in
their design [10, 11].
Our study aims to further explore the relationship be-
tween attitudes and medication adherence in patients
with diabetes taking oral anti-diabetics. Overall, we hope
to enhance the explanatory power of perceptions of Thai
patients with diabetes and their medication adherence.
We also aim to identify the facilitators and barriers of
patients with low adherence compared to those patients
with high adherence.
Methods
Study design, location and participants
A qualitative, case study exploratory approach was used
for this study. In-depth interviews of patients with type
2 diabetes was conducted by using semi-structured
guides at the Outpatient Department of the Department
of Family Medicine, Chiang Mai University, at Maharaj
Nakorn Chiang Mai Hospital, Chiang Mai, Thailand.
Participants were selected based on the following inclu-
sion criteria: (a) patient age at least 20 years old, with a
diagnosis of type 2 diabetes (confirmed by ICD-10 in the
hospital record system); (b) taking oral anti-diabetic
drugs, and (c) proficient in Thai language. Convenience
sampling was used, aiming for at least 20 participants at
which point saturation was expected based on previous
studies [12–14].
Data collection
Data collection consisted of 2 parts: (1) participant char-
acteristics and (2) in-depth interviews exploring percep-
tions and attitudes toward diabetes as they relate to
participant symptoms, medications, diagnosis, health
care and physician or health care staff interactions. Each
interview took between 30 and 45 min. Interviews were
conducted in Thai by a female study nurse trained in
qualitative interviewing with 3 years experience in con-
ducting qualitative interviews. The interviewer was not
directly involved in the usual care at the clinic. Members
of the research team observed the interviews (WJ and/or
KJ) and participants consented to having the interviews
recorded.
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Participant characteristics included age (< or ≥ 60
years) and gender. Level of adherence to medication was
assessed by asking 3 questions: “Do you take medication
regularly?” “How often do you forget?” and “Have you
ever stopped taking medication by yourself?” Adherence
was categorized into two groups, “low” or “high”, with
high adherence defined as taking medication regularly,
missing a dose ≤ 3 times in a month, and not prema-
turely discontinuing medications without physician
approval.
In-depth interview guides were created from medica-
tion adherence for chronic disease as outlined by WHO
[9], and focused on the five factors associated with ad-
herence to anti-diabetic medications (Table 1). It was
adapted to the local context by the research team (K.J.,
K.P. and W.J.). These guides, written in Thai language,
were piloted with a small number of patients, then cor-
rected and finalized.
Data analysis
Descriptive statistics were used for participant character-
istic. Qualitative analysis followed the WHO framework,
which provided a priori codes and definitions, with
emergent codes developed by W.J. and K.P. following
review of transcripts from the first few IDI. K.J. then
performed line-by-line inductive analysis according to
the agreed upon codes immediately after each subse-
quent IDI. W.J. reviewed and corroborated analysis for
K.J. using a small set of transcripts, and updated the
codebook accordingly. This iterative process helped
identify when and if saturation had been reached, at
which point data collection was stopped and no further
participants interviewed. Transcripts were then reviewed
by K.J. according to the finalized codebook, who per-
formed preliminary textual analysis with particular at-
tention paid to level of adherence (low vs high), gender,
and/or age. W.J. and K.J. reviewed and performed the-
matic analysis, which was then reviewed, discussed, and




At total of 24 participants were interviewed between
May and December 2016. Participants had a mean age
of 62 years, with 38% ≥ 60 years of age, and 62% female.
Sixty-six percent (16/24) were classified as having high
adherence (Table 2).
Factors related to medication adherence
Originally conceived as five factors affecting adherence,
patient- and condition-related factors were combined
upon analysis given that participants often discussed
these factors together. Thus, four themes were identified:
attitudes toward disease (patient- and condition-related
factors), attitudes toward treatment (therapy-related fac-
tors), attitudes toward family support (social- and
economic-related factors) and attitudes toward health
care team (health systems/HCT-related factors) (Table
3). These themes were compared for participants with
low and high adherence. Additional quotes supporting
the thematic analysis can be found in supplementary
Table 1.
Table 1 In-depth interview guide and the specific aspects of
anti-diabetic medication adherence covered
Factor discussed Questions
1. Condition-related factors
• The symptom at DM
diagnosis
How were you diagnosed with
T2DM
What were your symptoms?
• Perceived causes of T2DM What do you think caused your
T2DM?
• Feelings related to a T2DM
diagnosis
When you were diagnosed with
T2DM, were you concerned? Why or
why not?
2. Therapy-related factors
• Perceptions of long-term
medication treatment
What do you think or feel about
having to take medication long-
term for anti-diabetic treatment?
• Perception of the amount
and frequency of medication
used
How many pills do you take daily?
Do you think this is appropriate or
too much? Why or why not?
3. Health system/Health care
team (HCT)-related factor
How is your relationship with your
doctor or healthcare team?
4. Social/economic-related
factors
Who do you stay with?
Do they know about your T2DM
diagnosis?
How does your family support you?
5. Patient-related factors How often do you forget to take
your medicine? why?
Have you ever decide to stop by
yourself and why?
Table 2 Participant characteristics, (n = 24)
Factor
Age Mean age (SD) 62 (8.9)
< 60 years (n, %) 15 (62.5%)
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Attitudes toward disease
Participants’ attitudes toward disease were impacted by
symptoms (or lack thereof) experienced at the time of
diagnosis, understanding of disease causation, patho-
physiology, or natural progression of disease. Import-
antly, more severe disease, greater personal concern
about and/or negative experiences with disease symp-
toms or sequelae prompted better patient adherence to
anti-diabetic medications.
“I felt fatigue and my head was dizzy and felt tense
all day. I had tried herbs for 2 days but they didn't
work well. I didn’t know what was happening to me.
I felt really sick. I never had these symptoms before,
so I went to the doctor. At that time, I thought that I
needed to be admitted to the hospital. After the doc-
tor checked and found that my blood sugar was 400
[mg/dl] and my blood pressure was around 200
[mm Hg]...I have continued the medication regularly.
I am afraid to forget taking it because I don't want
my blood sugar to increase again. Since being diag-
nosed with diabetes, I have good control of my diet. I
don't eat snacks, sweets. I changed from sticky rice to
normal rice. I have increased vegetables and de-
creased fried food.”
—female, high adherence
As expected, symptoms (or lack thereof) could help
determine if patients took medications. The following
quote is particularly illustrative: a participant reports not
having diabetes symptoms at the time of his diagnosis, is
lulled by the lack of symptoms into poor medication ad-
herence, subsequently suffers a terrible symptomatic
event (stroke), which impresses upon him the import-
ance of taking anti-diabetic medications.
"I was diagnosed with diabetes about 7 years ago
after a regular checkup. I was not surprised as I was
quite fat at that time. I wasn’t very concerned be-
cause I thought my health was very good and I never
had any abnormal symptoms. So I decided not to
take any medication or see the doctors for 2 years.
Then it was suddenly worse when I suffered a stroke.
At that time, I thought it was a really terrible condi-
tion. I could not live without help from other people,
even get dressed or button my shirt. That caused me
great concern…I think diabetes is just as bad as can-
cer."
-- male, high adherence.
Attitudes toward treatment
Attitudes toward treatment focused predominantly on
taking medications, including the number of medications
required, their effects on disease sequelae, and associated
side effects. Concerns about long-term side effects of
medications—such as the risk of renal failure—made
participants reluctant to take medication. High adherers
believing the medication necessary and/or able to pre-
vent diabetic complications were more accepting of the
frequency and dosing of anti-diabetic medications.
"I know I have to take anti-diabetic medication for-
ever. This disease cannot be cured. I will take it
regularly until I die. I meet the doctor at every
Table 3 Themes and subthemes of IDI analysis following the




Symptoms at diagnosis and concerns
• Neurological symptoms: headache,
dizziness, stroke
• General symptoms: fatigue, thirsty, frequent
urinate
• Asymptomatic with incidental DM
diagnosis
Effect to ADLs/Non effect to ADLs
Health belief related to disease causation
- Irreversible condition (risk form older,
genetic disease)
- Behavior (lack of exercise, poor diet
control, obesity)






- Afraid of adverse effects from
medications, especially renal side effects
- Understand and accept medical
treatment
Adverse effect associated with treatment
- Has experienced
- Has experienced but corrected by health
care team






- No family involvement or reminders to
take medication
- Family support in various ways
(4) Attitudes toward
health care team
Providing treatment and advice
- Fear of diabetic complications
- Trust doctor’s advice
Doctor-patient relationship
- Doctor demonstrated compassion and
understanding
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appointment and take the pills when I return home.
If I have to visit my daughter in Japan, I will ask for
more pills. I never forget to take it. I take 6 pills for
diabetes and 1 for dyslipidemia."
Facilitator: "Do you think is it too many?"
"The amount of medication is lower than before....It's
necessary to take them. Some people who don't have
other diseases might take fewer pills than me. It's
reasonable because I have underlying disease. I want
to live a long with my family so I can take care of
them."— female, high adherence
However, low adherers had multiple reasons for not
taking medications, chief among them being: medication
adherence as burdensome; belief in alternative or trad-
itional cures; fear of medication side effects; and fatalistic
perspectives with regard to their diagnosis.
"I take anti-diabetics medication, 4 tablets, and also
one for hypertension and another one for hyperlipid-
emia for a total of 6 tablets a day. I usually leave
anti-diabetics medication for the evening. I don't
want to take it. I think it is too much. If I didn't have
other diseases, I won't have any problems with tak-
ing it. I also take herbs and hope that if my blood
sugar gets better I can stop taking these anti-diabetic
drugs. I fear that my kidneys will be destroyed. I saw
people get hemodialysis from renal failure. I fear to
be like that. The doctor told me to take medication
regularly, but if I forget just sometime at that even-
ing--it will not be a big problem, right?"
—female, low adherence
This quote exemplifies the kind of nuanced feelings
espoused by many participants with low adherence.
Comorbidities require a larger number of medications
that need to be taken over the course of a day, which
can be quite burdensome. Here we find that not only
are alternative therapies sought, but that they arise
from the desire for a cure hatched from a potential
misconception regarding the participant’s diagnosis.
This contrasts with the high-adhering participant
above, who internalizes the lack of cure as central to
her need to take medications regularly. Another con-
sistent theme—among both low and high adherers
alike—was the fear of medication side effects, espe-
cially their effects on the kidneys. Importantly, com-
plications such as diabetic nephropathy—the most
common cause of renal failure—didn’t seem to stoke
as heightened a fear for kidney health compared to
fears of medication-induced nephropathy. These mis-
understandings are described in detail by another par-
ticipant with low adherence:
"Right now, I take 2 tablets for diabetes, 1/2 tablet
for dyslipidemia and 1/2 tablet for hypertension. I
also take several herbs. My family suggests that these
herbs could lower blood sugar. My sister was diag-
nosed with diabetes and used to take anti-diabetic
medication and suffered many side effects. After tak-
ing herbs, these abnormalities had gone and their
blood sugar was controlled. The first time I took
medication, I didn’t feel good, sometimes I had pal-
pitations and dizziness. It was too many pills, my
body couldn't tolerate it, so I stopped taking them for
a while. After that, the doctor adjusted the medica-
tion and I had to be admitted to the hospital several
times from side effects. These days, I am fine. I am
OK with the amount of my medication. I take less
than before. In fact, I don't want to take anti-
diabetic medications. I think it can accumulate in
my body and end up with kidney disease or other
consequences. I saw my uncle, he took a lot of medi-
cation around 6-7 tablets every day until he suffered
renal failure and required a kidney transplant. I no-
tice that anyone who takes medication, they are
never cured from diabetes even taking it every day...-
like my uncle. You know…he had taken it every day.
I never saw his blood sugar controlled and worse
than that--he had to inject insulin every day."
—female, low adherence
Here we can identify how patients with diabetes may
ascribe beliefs and understandings about the disease to
their experienced reality. This patient in particular
followed the example of family members and their
family’s well-intentioned advice. However, there seems
to be some confusion in discerning effects of the disease
and its complications from medication side effects—or
even those of the herbal supplements. Although this par-
ticipant’s physician addressed potential side effects from
medications, there was still considerable disbelief that
anti-diabetic medicines prevent future sequelae. Finally,
as this quote exemplifies, participants often hinted at a
creeping fatalism about their condition that medications
would be unable to stymie the eventuality of diabetic
complications or, possibly, death.
Attitudes toward family support
There were various ways in which families supported pa-
tients that included reminding them to take medication,
helping prepare medications, cooking proper meals, and
taking participants to the hospital. In addition, partici-
pants noted that the love and care shown to them by
family members motivated participants to take care of
themselves by taking their medications.
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“When one of us [participant or the participant’s
husband] has free time, we will prepare our own
medication and each others, so we can know who
forgets taking their pills. We usually take medication
together after breakfast. He helps me a lot.”— fe-
male, high adherence
“My children usually remind me to not eat sweets or
fatty foods and to eat more fruits and vegetables.
They helped me prepare medication in the beginning
but now I can do by myself. They usually remind me
not to forget to take medication every day.”— female,
high adherence
Particpants suggested that not having the support of
attentive family members may in fact relate to poor
medication adherence:
“I prepare medication by myself, no one helps me.
My wife reminds me sometimes....once in a while...It
would be nice if she asked me every day. I under-
stand she is busy....has a lot of work to do.”— male,
low adherence.
Attitudes toward the health care team
The nature and character of the patient-physician rela-
tionship proved important in understanding medication
adherence among participants. Having a favorable atti-
tude toward one’s physician, participants’ perceived
compassion and understanding from one’s physician, or
feeling as though the doctor was an integral member of
the diabetes care team, could encourage participants to
take medication. Participants who believed they required
a physician’s help in spite of their self-management often
were concerned about the seriousness of their disease or
feared that they did not have a deep understanding of
diabetes. These participants sought out a physician as a
reliable source of advice. With such trust came a desire
to adhere to the health care teams’ recommendations,
including treatment.
"I decided to start anti-diabetic medication upon my
doctor’s advice. In fact, I can still do only lifestyle
modification. I know that I am quite old right now
and should do as the doctors suggest mostly. They
are specialized in this way, however, I wonder about
my own situation of having DM, and ask, "Why do I
have this disease?" and, "Is the suggestion from the
doctor clear?"— male, high adherence
"I don't stress about taking anti-diabetic medication.
The number that I should take is up to the doctor’s
suggestion. It' s important to believe the doctor, so I
take medication regularly. Someone may stop medi-
cation by themselves if their blood sugar is improve
but not me. I want to hear from my doctor first.
They are very nice to me. With these good advice
and their support, I feel 100% that I can control my
DM. Sometimes I work out-of-town as a tour guide,
but I still make sure to take the medication that the
doctor prescribed."— male, high adherence
Although both high and low adherers perceived that
the health care team provided knowledge of disease and
treatment, those with good adherence more often re-
ported a stronger feeling of empathy and understanding
on the part of their physician.
Discussion
This study sought deeper understanding into the adher-
ence to oral anti-diabetic medications among patients
with T2DM in Thailand, through a qualitative approach
that utilized a known WHO framework for understand-
ing factors that can enhance or impede medication ad-
herence. Four main themes were related to adherence to
medication regimens, including patients attitudes toward
the disease itself (patient- and condition-related factors);
attitudes toward medications (therapy-related factors);
attitudes toward social support (social/economic-related
factors); and attitudes toward the health care team
(health systems/HCT-related factors). The most com-
mon impediments to taking the anti-diabetic medica-
tions related to misconceptions about the disease itself
and often stemmed from distrust of anti-diabetic medi-
cations, and preference for traditional therapies in lieu
of doctor-prescribed regimens. Perceived symptoms,
particularly at the time of diagnosis or when experien-
cing diabetic complications, often related to improved
medication adherence. A strong family support system
could enhance medication adherence and overall aware-
ness for Thai patients with diabetes. Compassion from
health providers and feeling like an invested partner in
the patient-physician relationship could further compel
patients to take medications more regularly.
For this discussion, we focus on similarities between
ours and other studies in factors affecting medication
adherence among people with diabetes, and highlight
some implications for improving medication adherence
in a Thai context.
Attitudes toward disease
In this study, attitudes toward diabetes and the need to
take medications related to having severe symptoms
prior to diagnosis and/or having symptoms that dis-
turbed activities of daily living (ADLs). As in a study by
Brundisini et al., Thai participants' fears of the harms of
T2DM—either through immediate disruptions to ADLs
or long-term sequelae—served to heighten the partici-
pants’ desire to improve medication adherence [15]. By
contrast, lacking overt symptoms of disease may have
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the opposite effect, similar to studies elsewhere that note
that “normal” blood sugar levels were interpreted by pa-
tients to mean that they did not have to take medicines
[16, 17] .
With regard to symptoms (perceived or not), and
other attitudes that can lead to low medication adher-
ence, patient education may be the most promising
means to dispel misconceptions and engender more
positive attitudes toward self-management [18, 19].
Helping patients understand the pathophysiology of the
disease can help discern side effects related to medica-
tions compared to symptoms of disease, and can assuage
fears of medication-induced nephropathy. We note that
participants who viewed diabetes as an incurable but
manageable condition not only understood the import-
ance of adhering to medical regimens, but also espoused
healthy lifestyle choices such as limiting sugar and fat
consumption. Helping patients understand this distinc-
tion may curb fatalistic views of the disease. Although
not specifically emerging from our dataset, we are
reminded that stigma related to diabetes can make pa-
tients reluctant to intiate treatment and maintain adher-
ence [18].
Attitudes toward treatment
Findings from this study echo studies highlighting poor
medication adherence due to fears of side effects and a
preference for herbs or local alternatives. Fears among
participants that long-term treatment would cause renal
failure led to intentional and/or unconsciously poor
medication adherence. We found that the “burden” asso-
ciated with oral anti-diabetic medications was largely
perceived instead of being associated with the actual
number of medications to be taken, as participants who
understood medication was necessary in preventing dia-
betic complications could accept whatever amount of
medication needed. Negative attitudes toward anti-
diabetic medications cultivated a sense among partici-
pants that oral anti-diabetics were too burdensome re-
gardless of the amount, leading to conscious or
unconscious non-adherence. As in a meta-analysis of
T2DM patients’ and providers’ differing perspectives on
medication nonadherence, this study also finds that
intentional non-adherence was an effort to avoid per-
ceived side effects of anti-diabetic medications [15]. A
study by Sohal et al. characterized barriers and facilita-
tors for T2DM management in South Asia, noting mis-
conceptions such as reduced or missed doses could
reduce medication side effects, and a preference for
herbal or traditional treatments perceived as safer than
western medications [20].
As in other studies, our study implies that more con-
scious efforts to counter beliefs that medication side ef-
fects make people sicker can improve medication
adherence [17, 19]. An important example of this is the
fear of hypoglycemia, which has been attributed as a
cause for patients to stop or self-adjust regimens [21],
and adverse events associated with anti-diabetics have
made patients in neighboring Malaysia [22] and further
afield in Bangladesh [13] reluctant to adhere to thera-
peutic regimens. In our study, some participants experi-
enced medication side effects but were able to continue
medication treatment after their physician adjusted their
medication regimen. Therefore, in addition to allaying
fears of medication side effects, clear open discussions
between patients and their physicians in the event of
side effects is essential. Multi-faceted strategies to pro-
mote adherence may be tailored to the Thai context and
focus on education to adresss misconceptions and advise
on missed doses, medication reminders, and feedback on
the impact of medication on glycemic control [18].
Attitudes toward family support
Our study findings are similar to studies identifying the
supportive actions families of patients with diabetes can
take to enable higher quality of life and better control of
the disease and its complications [23–25]. Such actions
include encouraging and supportive communication,
and practical considerations found in our study such as
managing diet, medications, and home blood glucose
monitoring [23]. Not only were these family interactions
important for high adherence among our study partici-
pants, but their very absence seemed to risk poor
adherence.
Hence, as education seems the likely implication of
our findings in the Thai context, encouraging family
members to get involved in diabetic treatment as part of
the care team can be very helpful [26]. Families are cru-
cial for managing chronic disease [25]—possibly all the
more important in LMIC settings in Asia as demon-
strated in Thailand, Cambodia, and India [5, 27, 28]—
and a systematic review suggests that developing inter-
ventions to enhance family support of patients with dia-
betes can improve health outcomes of patients with
uncontrolled glycemic levels [24].
Attitudes toward health care team
The study highlights that the relationship a patient has
with their health care team and their physician plays an
important role in Thai patients adherence to medica-
tions. As in other Asian communities, we suspect that
Thai patients often consider the physician as the au-
thoritative source of diabetes knowledge and manage-
ment [20]. However, this implies a power dynamic that
may prevent patients from disclosing failure to comply
with their physician’s recommendations. For Thai
patients, stronger perceived empathy from the health
care team and their physicians was noted among high
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adherers. This is something to be strived for as evidence
from Bangladesh suggests that a lack of empathy and re-
assurance from participants’ physicians were barriers to
effective diabetes management [29]. Training multidis-
ciplinary care teams, including nurses, dieticians, phar-
macists, and social workers in counselling and
motivational interviews could be useful to enhance self-
management skills and adherence to medications in pa-
tient with diabetes [30, 31].
Hence, implications for the Thai context should train
health workers and multidisciplinary teams with an ex-
plicit focus on eliciting patient’s feelings, beliefs and con-
cerns about illness, and involve patients and their
families in decision-making [32]. Rezaei et al. suggest
that gaining the patient’s trust can promote the relation-
ship and medical teams should attempt to tailor care
programs to each patient based on their lived experi-
ences and unique challenges to increase their adherence
to treatment [33]. An easy plan of treatment, specific to
each patient’s lifestyle, and acknowledging an individ-
ual’s limitation due to social isolation, age or limited
health literacy [28] can help ensure that taking medica-
tion is a part of routine, daily activities. In Thailand,
there is evidence that the benefits of using a multidiscip-
linary team to provide holistic care for patient with dia-
betes may also extend beyond medical adherence [34].
Limitations
A key limitation is generalizability of findings given a
specific study population in northern Thailand. How-
ever, we found that these factors are similar for other
parts of Thailand, and are reassured by similar findings
from other populations specifically in Asia and more
broadly in LMIC settings. Given that a study nurse con-
ducted the interviews, social desirability bias may have
occurred. However, data saturation was a key indicator,
and interview data from low and high adherers alike met
this threshold. This study may have further benefitted
from interviews with physicians and other members of
the care team. A more robust measure of adherence and
treatment outcomes, such as HbA1c, could have made
for a stronger conclusion about a given patient’s true ad-
herence status, however, additional tests would have in-
curred substantial costs and was not possible for this
study.
Conclusions
Medication adherence in Thai patients with diabetes re-
quires support from both the health care providers and
the family. The patient’s perception of the doctor’s con-
cern creates greater patient trust in the health care team.
This trust, along with family support, helps deepen pa-
tients’ understanding of their disease, accept the chronic
nature of the disease, and engenders a positive attitude
towards taking medication that can improve medication
adherence. Our findings add to literature attempting to
understand patient adherence for diabetes, which may
inform efforts to address the growing need to improve
long-term, chronic disease care in LMIC settings.
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